BridgeBio Pharma (BBIO) Return on Sales [ROS] (2020 - 2026)
BridgeBio Pharma (BBIO) posted Return on Sales [ROS] of -43.94% for Q2 2026, up 77.50 percentage points from -121.45% a year earlier and up 10.53 percentage points from the prior quarter.
BridgeBio Pharma (BBIO) Return on Sales [ROS] (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at BridgeBio Pharma was -69.81%, up 208.56 percentage points year-over-year; for FY2025, it came in at -104.25%, up 162.97 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +5647.74 percentage points (FY2020 to FY2025).
- In prior years, BridgeBio Pharma's Return on Sales [ROS] was -267.22% in FY2024 (+6261.53 pp), -6528.75% in FY2023 (-5869.11 pp), -659.65% in FY2022 (+167.47 pp) and -827.12% in FY2021 (+4924.88 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Sales [ROS] since Q1 2024.
- On a year-over-year basis, Return on Sales [ROS] has increased in each of the last five quarters, with an average year-over-year change of +2726.14 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q4 2021, with a gain of 103213.96 percentage points; the weakest was Q3 2022, with a drop of 31822.06 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -54.47% (Q1 2026), -90.52% (Q4 2025) and -120.30% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 28.37% |
| 10 | BridgeBio Pharma | 13.07 Bn | 10.18 Bn | 228.63 Mn | -43.94% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -43.94% |
| Mar 31, 2026 | -54.47% |
| Dec 31, 2025 | -90.52% |
| Sep 30, 2025 | -120.30% |
| Jun 30, 2025 | -121.45% |
| Mar 31, 2025 | -89.49% |
| Dec 31, 2024 | -3,842.69% |
| Sep 30, 2024 | -7,018.67% |
| Jun 30, 2024 | -8,096.82% |
| Mar 31, 2024 | 0.16% |
| Dec 31, 2023 | -10,167.11% |
| Sep 30, 2023 | -3,854.61% |
| Jun 30, 2023 | -8,903.05% |
| Mar 31, 2023 | -6,909.26% |
| Dec 31, 2022 | -6,910.80% |
| Sep 30, 2022 | -38,200.00% |
| Jun 30, 2022 | -108.72% |
| Mar 31, 2022 | -10,252.54% |
| Dec 31, 2021 | -1,285.22% |
| Sep 30, 2021 | -6,377.94% |
BridgeBio Pharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();